Welcome!
ALERT Pls. ensure to update any @iupui.edu email addresses within your user account, core account, etc. profile to reflect @iu.edu, per IU's One Mail project.
Solutions for many iLab inquiries may be found on the IU iLab FAQ page. Should further assistance be needed, contact iLab support via ilab-support@agilent.com. The Agilent iLab Help Resources Hub is also a useful page.
(hide this warning on this page)The goal of the IU Gene Therapy Testing Laboratory is to serve as a national resource for gene therapy work. Our research focus is on using viral based gene transfer as a means of introducing genetic sequences that will correct mutations and ameliorate disease. To date we have certified over 30 products for Phase I/II trials. We have published extensively on release testing to meet FDA requirements. We are currently the NIH/NHLBI National Gene Vector Biorepository (www.ngvbcc.org) which assists investigators in meeting FDA requirements associated with preclinical and clinical gene therapy. Our research looks at ways to improve vector production and certification testing.
Ken Cornetta | Director | (317) 278-1295 | kcornett@iu.edu | R3-C649
Andrea Gunawan | Business Manager | (317) 274-4519 | amgunawa@iu.edu | R3-C650
| Location | Hours |
|
980 W. Walnut St. R3-C602 Indianapolis, IN 46202 |
8 am - 5 pm Monday - Friday |
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Andrea Gunawan |
Manager
|
317-274-4519
|
amgunawa@iu.edu
|
R3-C50
|
